Pinealon

Pinealon is a synthetic short-chain peptide (a tripeptide composed of glutamic acid, aspartic acid, and arginine) belonging to the family of regulatory "cytomedine" peptide bioregulators discussed in the gerontology and neuroscience literature. It is supplied here in lyophilized powder form for licensed-practitioner research and professional use within the Cognitive & Longevity category. Pinealon is not approved by the FDA for therapeutic use and is provided solely as a research compound and professional reference material. It is most often discussed in preclinical and experimental literature in the context of neuronal cell models, central-nervous-system aging research, and short-peptide regulation of gene expression. Any reference to effects or outcomes is descriptive of published research only; individual results vary, and nothing here constitutes a clinical or therapeutic claim.

• Investigated in preclinical literature in the context of neuronal cell survival and resistance to oxidative or hypoxic stress in cell-model systems; individual results vary
• Studied in experimental aging and neurogerontology research for its proposed role in central-nervous-system regulation
• Examined in research settings for associations with markers of learning, memory, and cognitive function in animal models
• Explored in laboratory studies for peptide-mediated effects on gene expression and protein synthesis in neural tissue
• Referenced in longevity-focused research as a representative short regulatory peptide and bioregulator alongside related compounds

Reference only: the lyophilized peptide is typically reconstituted with bacteriostatic water or another sterile diluent selected by the provider, with the diluent directed slowly against the vial wall and the vial swirled gently rather than shaken to help preserve peptide integrity. Unreconstituted vials are generally stored frozen or refrigerated and kept sealed; after reconstitution the solution is commonly kept refrigerated (approximately 2-8 C), protected from light and heat, and handled under aseptic technique. Avoid repeated freeze-thaw cycles, and discard if the solution shows cloudiness, particulates, or discoloration. This information addresses storage and handling only and does not specify dosing. All clinical protocols, indications, and administration decisions are determined solely by the licensed ordering provider. This is reference information for research and professional use, not medical advice.

A per-lot Certificate of Analysis, HPLC purity profile, and mass-spectrometry verification are available on request for this product. Ask your account manager for the current lot documentation.

In the published research literature, Pinealon is described as a short regulatory peptide that has been studied for proposed interactions with cellular DNA and chromatin that may modulate gene expression and protein synthesis, a mechanism hypothesized for the broader class of peptide bioregulators. Experimental models have explored its proposed influence on antioxidant-related and anti-apoptotic pathways, with researchers hypothesizing a role in neuronal cell viability under stress conditions such as oxidative load or hypoxia. These mechanisms are described as proposed and under study rather than established; findings are largely preclinical, and individual results vary.